Madrigal Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Madrigal Pharmaceuticals, Inc. (MDGL) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.100.100.330.040.050.440.48
Short-Term Investments0.830.530.030.230.230.000.00
Cash & Short-Term Investments0.930.630.360.270.280.440.48
Accounts Receivable0.050.000.000.000.000.000.00
Inventory0.030.000.000.000.000.000.00
Other Current Assets0.010.000.000.000.000.000.00
Total Current Assets1.030.640.360.270.290.440.49
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.00
Other Non-Current Assets0.000.000.000.000.000.000.00
Total Non-Current Assets0.010.000.000.000.000.000.00
Total Assets1.040.640.360.270.290.440.49
Current Liabilities
Accounts Payable0.040.030.020.020.000.020.01
Short-Term Debt0.000.000.000.000.000.000.00
Accrued Liabilities0.090.090.090.060.050.000.00
Other Current Liabilities0.120.020.010.000.000.000.00
Total Current Liabilities0.170.120.120.080.050.030.01
Non-Current Liabilities
Long-Term Debt0.120.120.050.000.000.000.00
Other Non-Current Liabilities0.000.000.000.000.000.000.00
Total Non-Current Liabilities0.120.120.050.000.000.000.00
Total Liabilities0.290.240.170.080.050.030.01
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-1.80-1.34-0.96-0.67-0.43-0.22-0.14
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital2.561.741.160.860.670.640.62
Shares Outstanding0.020.020.020.020.000.000.00
Total Stockholders' Equity0.750.410.200.200.240.420.48
Total Liabilities & Equity1.040.640.360.270.290.440.49